Medical Cannabis for all Canadians
Questions & Answers
MyMedi.ca is required to meet strict quality and safety standards set by Health Canada.
There is a potential for interactions with some CYP enzymes.
The efficacy and safety of medical cannabis has been established in robust and ongoing clinical trials including the Quebec Cannabis Registry and others conducted by major universities and hospitals.
The most common AEs were mild to moderate and included somnolence, amnesia, cough, nausea, dizziness, euphoria, hyperhidrosis and paranoia. Refer to the Health Canada Information for Healthcare Professionals Monograph for a full list of adverse events.
Cannabis dosing varies by the individual and treatment goal. It relies to a great extent on self-titration for a patient to find the lowest effective dose.
No death from overdose of cannabis has been reported.